Clinical trial Recruiting at 1 site Observational Ages 18 and up

Exploring the link between gut microbiome and cancer-related fatigue and cognition

Official title: Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

Run by The University of Texas Medical Branch, Galveston · NCT06098404 · Data updated 2026-11-12

This study is trying to see if the bacteria in the gut of cancer patients affects their feelings of tiredness and problems with thinking while they are getting treatment.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorThe University of Texas Medical Branch, Galveston
Academic / other
Locations1 site (Galveston, Texas)
StatusRecruiting
StartedMarch 4, 2024
Main results expectedOctober 2026
Study endsOctober 2026
Registry record updatedDecember 16, 2025
Trial IDNCT06098404 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and over who have a current diagnosis of cancer.

Probably not a fit

Patients who are pregnant or lactating, or those with other medical conditions that exclude them from participation, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to characterize the gut microbiome and assess levels of fatigue and cognitive impairment in cancer patients undergoing standard treatment. It focuses on understanding the relationship between microbiome composition and symptoms of cancer-related cognitive impairment (CRCI) and fatigue, which are common and debilitating issues faced by cancer patients. By employing consistent methods to evaluate these symptoms across various cancer types and treatments, the study seeks to identify shared mechanisms that may contribute to these symptoms. The findings could provide insights into potential interventions to alleviate these challenges.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of fatigue and cognitive impairment in cancer patients.

How similar studies have gone: While the relationship between gut microbiome and cancer-related symptoms is being explored, this specific approach is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Current diagnosis of cancer.
2. Ages 18 and over.
3. Has access to a device (smart phone, computer, tablet) with internet access.
4. Participant is willing and able to give informed consent for participation in the study.

Exclusion Criteria:

1. Females who are pregnant or lactating.
2. Other medical conditions or medications deemed exclusionary by the study investigators.

Where it's running

  • The University of Texas Medical Branch
    Galveston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Melinda Sheffield-Moore, PhD — University of Texas
  • Study coordinator: Kate Randolph, BS
  • Email: kmrandol@utmb.edu
  • Phone: 409-223-7891

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.